IDG Contributor Network: Price of entry or corporate strategy: how pharma and biotech are approaching digital health

The high costs of drug discovery and commercialization, looming patent cliffs, and increasing regulatory pressure on drug pricing have created a perfect storm of margin and growth pressures on the pharma sector. In an apparent response to these pressures, M&A activity in pharma is back. This month, Bristol Myers Squibb’s announced its $74 Billion acquisition…

ITIL 4: ITSM gets agile

ITIL-based organizations take note: The popular framework has undergone a significant overhaul aimed at modernizing IT service management (ITSM) into a more agile, value-driven business asset. ITIL was last updated in 2011, but it was only a small refresh — the 2019 overhaul of ITIL is on par with the 2007 update, which brought significant…